The Effects of Bilateral Cerebellar rTMS on Cortical Function
Primary Purpose
Dysphagia, Swallowing Disorder
Status
Completed
Phase
Not Applicable
Locations
United Kingdom
Study Type
Interventional
Intervention
Cerebellar targeted rTMS
Sponsored by
About this trial
This is an interventional basic science trial for Dysphagia
Eligibility Criteria
Inclusion Criteria:
• Adults above 18 years of age
Exclusion Criteria:
- Epilepsy
- Cardiac pacemaker
- Previous brain surgery
- Previous swallowing problems
- The use of medication which acts on the central nervous system
- Any implanted metal in the head
Sites / Locations
- Upper G.I laboratory, Salford Royal Hospital
Arms of the Study
Arm 1
Arm 2
Arm Type
Active Comparator
Experimental
Arm Label
Unilateral cerebellar rTMS
Bilateral cerebellar rTMS
Arm Description
Outcomes
Primary Outcome Measures
PMEP
Pharyngeal motor evoked potential amplitude (PMEP) amplitude
Swallowing behaviour
Swallowing accuracy (number of correct swallows on target out of 10 using a swallowing reaction time task)
Secondary Outcome Measures
Full Information
NCT ID
NCT03831789
First Posted
February 4, 2019
Last Updated
June 8, 2022
Sponsor
University of Manchester
1. Study Identification
Unique Protocol Identification Number
NCT03831789
Brief Title
The Effects of Bilateral Cerebellar rTMS on Cortical Function
Official Title
The Neurophysiological Effects of Bilateral Cerebellar rTMS on Cortical Activity and Swallowing Function
Study Type
Interventional
2. Study Status
Record Verification Date
June 2022
Overall Recruitment Status
Completed
Study Start Date
April 8, 2019 (Actual)
Primary Completion Date
March 30, 2020 (Actual)
Study Completion Date
April 30, 2020 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
University of Manchester
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No
5. Study Description
Brief Summary
Swallowing function is controlled by two swallowing centres (one on each half of the brain). There is a dominant and non-dominant swallowing centre. Damage to any part of the brain can lead to swallowing problems, for example in strokes. Recovery of the ability to swallow is associated with increased activity (compensation) over the undamaged centre. The cerebellum is an area of the brain involved in the control and modulation of muscle movements. It is found at the back of the skull.
Over the past few years studies have tried to improve swallowing function using techniques to stimulate regions of the brain and encourage compensation. Repetitive transcranial magnetic stimulation (rTMS) is a technique which can temporarily increase or suppress activity over regions of the brain.
This study will use cerebellar rTMS to attempt to increase activity over the cortical swallowing centres. It will also temporarily suppress activity over the dominant swallowing centre (a virtual lesion) before using cerebellar targeted rTMS to attempt to reverse this suppressive electrical and behavioural effect. The investigators aim to compare the effectiveness of rTMS over the two halves of the cerebellum to rTMS over one half of the cerebellum in increasing activity over the swallowing centres and reversing the suppressive effects of low frequency rTMS 'virtual lesion' over the dominant swallowing centre.
Detailed Description
Summary
To determine if 10 Hertz bilateral cerebellar rTMS is more effective than 10 Hertz unilateral cerebellar rTMS or sham in:
Increasing PMEP amplitude over the pharyngeal cortical area
Reversing focal cortical suppression to the pharyngeal motor cortex induced by a 'virtual lesion'.
This experiment will be performed over six visits to the laboratory.
Experiment Previous studies in our laboratory have shown that focal suppression of the strongest pharyngeal motor representation (1 Hz rTMS for 10 minutes at an intensity of 120% of resting motor threshold) transiently suppresses cortical swallowing activity as measured by PMEP amplitude and function as measured by a swallowing reaction time task, for up to an hour after cessation of rTMS (14, 15). This temporary suppressive effect has been called a cortical 'virtual lesion'. This model has been utilised in several studies (2, 14, 15) as a way of trialling the effects of neurostimulatory interventions in a safe, controlled environment in healthy subjects, before proceeding to patient trials. Studies have also shown that interventions which are capable of reversing the effects of focal cortical suppression more quickly than would ordinarily be the case if the suppressive effects were left to dissipate naturally, are effective in improving post stroke dysphagia (16).
The optimal stimulation sites for the pharyngeal cortical areas and cerebellum will have their resting motor thresholds identified and marked using single pulse TMS with a figure of eight coil (wing diameter of 90mm). Anatomical landmarks will be used to help guide neuronavigation. The vertex of the head will be identified with a tape measure as will the inion (the most prominent part at the back of the skull) (1). Studies have demonstrated that the pharyngeal cortical area is found anterior and lateral to the vertex while both halves of the cerebellum lie inferior and lateral to the inion (1, 15).
Visits 1- 2 (Aim 1 Measurement of Pharyngeal Cortical MEP Amplitude) Cortical and cerebellar PMEPs will be measured by administering single pulse TMS at 10% of stimulator output above resting motor threshold. Ten stimuli (trials) will be given over the pharyngeal motor cortex with greater neuronal activity - lower resting membrane threshold. This stimulus intensity has been shown to give the best reproducibility results for viscerosomatic TMS studies (15). Cerebellar MEPs will be measured by administering 5 stimuli (trials) of single pulse TMS over the cerebellum.
Participants will be randomised to receive one of two cerebellar rTMS interventions (on separate visits):
Real 10 Hz cerebellar rTMS (250 pulses) to the right cerebellar hemisphere (unilateral)
Real 10 Hz cerebellar rTMS (250 pulses) to the right and left cerebellar hemispheres (bilateral)
The effects of the interventions on PMEPs over cortical pharyngeal areas bilaterally will be measured immediately and every fifteen minutes for an hour post intervention. All data will be compared to baseline MEP amplitude.
Visits 3-4 (Aim 2 Measurement of Pharyngeal Cortical MEP Amplitude after Virtual Lesion) A 'virtual lesion' (1 Hz rTMS for 10 minutes at an intensity of 120% of resting motor threshold) will be administered by holding a figure of eight coil flat over the cortical pharyngeal representation with the highest neurological activity - this is the representation with the lowest resting membrane potential (15). After which, over two visits to the laboratory, unilateral and bilateral cerebellar rTMS will administered to the cerebellar sites identified earlier.
During these two visits participants will have their baseline pharyngeal MEPs measured in a similar manner to visits 1-2. After focal cortical suppression subjects will be randomised to receive one of two cerebellar rTMS interventions (on separate visits):
Real 10 Hz cerebellar rTMS (250 pulses) to the right cerebellar hemisphere (unilateral)
Real 10 Hz cerebellar rTMS (250 pulses) to the right and left cerebellar hemispheres (bilateral)
The effects of the interventions on PMEPs over cortical pharyngeal areas bilaterally will then be measured immediately and every fifteen minutes for an hour post intervention before being compared to baseline.
Visits 5-6 (Aim 2 Measurement of Swallowing Accuracy Using Reaction Time Task)
During these two visits, subjects will have baseline measurements of normal, fast and challenge swallows (*see below for measurement procedure). After focal cortical suppression subjects will be randomised to receive one of two cerebellar rTMS interventions (on separate visits):
Real 10 Hz cerebellar rTMS (250 pulses) to the right cerebellar hemisphere (unilateral)
Real 10 Hz cerebellar rTMS (250 pulses) to the right and left cerebellar hemispheres (bilateral)
The effects of the interventions on swallowing function will then be measured by repeating normal, fast and challenge swallow reaction times, immediately and at regular intervals for an hour post intervention.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Dysphagia, Swallowing Disorder
7. Study Design
Primary Purpose
Basic Science
Study Phase
Not Applicable
Interventional Study Model
Crossover Assignment
Model Description
All participants over the course of three visits will either have: unilateral cerebellar rTMS or bilateral cerebellar rTMS. However, the order in which they will receive these interventions will be randomly allocated.
Masking
Participant
Masking Description
All participants will be masked as to which of the three study arms they have been allocated. All participants over the course of three visits will either have: unilateral cerebellar rTMS or bilateral cerebellar rTMS. However, as specified earlier the order in which they will receive these interventions will be randomly allocated.
Allocation
Randomized
Enrollment
15 (Actual)
8. Arms, Groups, and Interventions
Arm Title
Unilateral cerebellar rTMS
Arm Type
Active Comparator
Arm Title
Bilateral cerebellar rTMS
Arm Type
Experimental
Intervention Type
Device
Intervention Name(s)
Cerebellar targeted rTMS
Intervention Description
10 Hz cerebellar rTMS (250 pulses)
Primary Outcome Measure Information:
Title
PMEP
Description
Pharyngeal motor evoked potential amplitude (PMEP) amplitude
Time Frame
Every 15 minutes for an hour after the intervention.
Title
Swallowing behaviour
Description
Swallowing accuracy (number of correct swallows on target out of 10 using a swallowing reaction time task)
Time Frame
Every 15 minutes for an hour after the intervention.
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria:
• Adults above 18 years of age
Exclusion Criteria:
Epilepsy
Cardiac pacemaker
Previous brain surgery
Previous swallowing problems
The use of medication which acts on the central nervous system
Any implanted metal in the head
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Shaheen Hamdy
Organizational Affiliation
University of Manchester
Official's Role
Principal Investigator
Facility Information:
Facility Name
Upper G.I laboratory, Salford Royal Hospital
City
Manchester
State/Province
Greater Manchester
ZIP/Postal Code
M6 8HD
Country
United Kingdom
12. IPD Sharing Statement
Plan to Share IPD
No
IPD Sharing Plan Description
IPD containing personal identifiable information will not be published. However, anonymised PMEP and swallowing timing data will be published.
Learn more about this trial
The Effects of Bilateral Cerebellar rTMS on Cortical Function
We'll reach out to this number within 24 hrs